Cost-effectiveness analysis of single fraction of stereotactic body radiation therapy compared with single fraction of external beam radiation therapy for palliation of vertebral bone metastases

International Journal of Radiation Oncology Biology Physics

Volumn 91, Issue 3, 2015, Pages 556-563

  Kim, Hayeon ^a   Rajagopalan, Malolan S ^a   Beriwal, Sushil ^a   Huq, M Saiful ^a   Smith, Kenneth J ^b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS; HEALTH INSURANCE; MARKOV PROCESSES; MUSCULOSKELETAL SYSTEM; PATHOLOGY; RADIATION; RADIOTHERAPY; SENSITIVITY ANALYSIS; UNCERTAINTY ANALYSIS;

COST EFFECTIVENESS ANALYSIS; COST-EFFECTIVE APPROACH; EXTERNAL BEAM RADIATION THERAPY; PROBABILISTIC SENSITIVITY ANALYSIS; QUALITY ADJUSTED LIFE YEARS; RADIATION THERAPY ONCOLOGY GROUPS; STEREOTACTIC BODY RADIATION THERAPY; TRANSITION PROBABILITIES;

COST BENEFIT ANALYSIS;

ANALGESIA; ARTICLE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MEDICARE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; REIMBURSEMENT; SPINE METASTASIS; STEREOTACTIC BODY RADIATION THERAPY; BONE NEOPLASMS; COST BENEFIT ANALYSIS; ECONOMICS; MORTALITY; PALLIATIVE THERAPY; PROCEDURES; RADIATION DOSE; RADIOSURGERY; SECONDARY; SENSITIVITY AND SPECIFICITY;

BONE NEOPLASMS; COST-BENEFIT ANALYSIS; HUMANS; MARKOV CHAINS; PALLIATIVE CARE; PROBABILITY; QUALITY-ADJUSTED LIFE YEARS; RADIOSURGERY; RADIOTHERAPY; RADIOTHERAPY DOSAGE; SENSITIVITY AND SPECIFICITY;

EID: 84923227990     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.10.055     Document Type: Article

References (35)

1. D. Howell, J.L. James, and W.F. Hartsell Single fraction radiotherapy vurses multifraction radiotherapy for palliation of painful vertebral bone metastases - equivalent efficacy, less toxicity, more convenient Cancer 119 2013 888 896
2. S. Lutz, L. Berk, and E. Chang Palliative radiotherapy for bone metastases: An ASTRO evidence based guideline Int J Radiat Oncol Biol Phys 79 2011 965 976
3. Radiation Therapy Oncology Group (RTOG) 0631. Phase II/III study of image guided radiosurgery/SBRT for localized spine metastases. http://www.rtog.org/ClinicalTrials/ProtocolTable.
4. E. Chow, K. Harris, and G. Fan Palliative radiotherapy trials for bone metastases: A systematic review J Clin Oncol 25 2007 1423 1436
5. M. Huisman, M.A. van den Bosch, and J.W. Wijlemans Effectiveness of reirradiation for painful bone metastases: A systematic review and meta-analysis Int J Radiat Oncol Biol Phys 84 2012 8 14
6. W.F. Hartsell, C.B. Scott, and D.W. Brunner Randomized trial of short versus long course radiotherapy for palliation of painful bone metastases J Natl Cancer Inst 97 2005 798 804
7. W.F. Hartsell, A.A. Konski, and S.S. Lo Single fraction radiotherapy for bone metastases: Clinically effective, time efficient, cost conscious and still underutilized in the United States? Clin Oncol (R Coll Radiol) 21 2009 652 654
8. S. Ryu, J. Rock, and M. Rosenblum Pattern of failure after single dose radiosurgery for single spinal metastases J Neurosurg 101 2004 402 405
9. P.C. Gerszten, S.A. Burton, and C. Ozhasoglu Stereotactic radiosurgery for the spine metastases from renal cell carcinoma J Neurosurg Spine 3 2005 288 295
10. S. Ryu, S. Chang, and D. Kim Image guided hypo-fractionated stereotactic radiosurgery to spinal lesions Neurosurgery 49 2001 838 846
11. J.W. Degan, G.J. Gagnon, and J.M. Voyadzis CyberKnife stereotactic radiosurgical treatment of spinal tumors for pain control and quality of life J Neurosurg Spine 2 2005 540 549
12. P.C. Gerszten, S.A. Burton, and A.E. Quinn Radiosurgery for the treatment of spinal melanoma metastases Stereotact Funct Neurosurg 83 2005 213 221
13. P.C. Gerszten, S.A. Burton, and C.P. Belani Radiosurgery for the treatment of spinal lung metastases Cancer 107 2006 2653 2661
14. P.C. Gerszten, S.A. Burton, and W.C. Welch Single fraction radiosurgey for the treatment of spinal breast metastases Cancer 104 2005 2244 2254
15. S. Ryu, F.F. Yin, and J. Rock Image guided and intensity modulated radiosurgery for spinal metastases Cancer 97 2003 2013 2018
16. S. Ryu, J.J. Jin, and R.Y. Jin Partial volume tolerance of spinal cord and complication of single dose radiosurgery Cancer 109 2007 628 636
17. S. Ryu, R. Jin, and J.J. Jin Pain control by image guided radiosurgery for solitary spinal metastasis J Pain Symptom Manage 35 2008 292 298
18. J.S. Wu, J.R. Wong, and M. Johnson Cancer Care Ontario practice guidelines initiative supportive care group. Meta-analysis of dose fractionation radiotherapy trials for the palliation of painful bone metastases Int J Radiat Oncol Biol Phys 55 2003 594 605
19. E. Chow, Y.M. van der Linden, and D. Roose Single versus multiple fractions of repeat radiation for painful bone metastases: A randomized, controlled, non inferiority trial Lancet Oncol 15 2014 164 171
20. M. Haley, P. Gerszten, and D.E. Heron Efficacy and cost effectiveness analysis of external beam and stereotactic body radiation therapy in the treatment of spine metastases: A matched pair analysis J Neurosurg Spine 14 2011 537 542
21. D.E. Heron, M.S. Rajagopalan, and B. Stone Single-session and multisession CyberKnife radiosurgery for spine metastases - University of Pittsburgh and Georgetown University experience J Neurosurg Spine 17 2012 11 18
22. F.J. Papatheofanis, E. Williams, and S.D. Chang Cost utility analysis of the Cyberknife system for metastatic spinal tumors Neurosurgery 64 2Suppl 2009 A73 A83
23. A. Konski, J. James, and W. Hartsell Economic analysis of RTOG 97-14 J Clin Oncol 32 2009 423 428
24. W.B. Van den Hout, Y.M. van der Linden, and E. Steenland Single versus multiple fraction radiotherapy in patients with painful bone metastases: Cost utility analysis based on a randomized trial J Natl Cancer Inst 95 2003 222 229
25. J. Hutton, R. Brown, and M. Borowitz A new decision model for cost-utility comparisons of chemotherapy in recurrent metastatic breast cancer Pharmacoeconomics 9 1996 8 22
26. G. Mooney, and S. Jan A second opinion. Cost utility analysis and varying preferences for health Health Policy 41 1997 201 205
27. M. Van den Brink, W.B. Van den Hout, and A.M. Stiggelbout Cost utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision J Clin Oncol 22 2004 244 253
28. C.A. Dooms, Y.N. Lievens, and J.F. Vansteenkiste Cost utility analysis of chemotherapy in symptomatic advanced non small cell lung cancer Eur Respir J 27 2006 895 901
29. R.S. Braithwaite, D.O. Meltzer, and J.T. King Jr. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? Med Care 46 2008 349 356
30. A. Laupacis, D. Feeny, and A.S. Detsky How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations CMAJ 146 1992 473 481
31. P.A. Ubel, R.A. Hirth, and M.E. Chernew What is the price of life and why doesn't it increase at the rate of inflation? Arch Intern Med 163 2003 1637 1641
32. C.C. Earle, R.H. Chapman, and C.S. Baker Systematic overview of cost-utility assessments in oncology J Clin Oncol 18 2000 3302 3317
33. A.H. Briggs, R. Goeree, and G. Blackhouse Probabilistic analysis of cost-effectiveness models: Choosing between treatment strategies for gastroesophageal reflux disease Med Decis Making 22 2002 290 308
34. E. Chan-Seng, M. Charissoux, and A. Larbi Spinal metastases in breast cancer: Single center experience World Neurosurg 2014 Aug 9 [Epub ahead of print]
35. L. Bollen, Y.M. Van der Linden, and W. Pondaag Prognostic factors associated with survival in patients with symptomatic spinal bone metastases: A retrospective cohort study of 1043 patients Neuro Oncol 16 2014 991 998